文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

加速消除麻疹和风疹的研究重点:一项横断面网络调查

Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
PubMed 文献 · Vaccine · 2019-03-18

为识别麻疹和风疹研究重点,M&RI研究创新工作组开展横断面网络调查,征集科学和项目专家意见。调查覆盖流行病学与经济学、新工具、免疫策略与疫情应对、疫苗需求与沟通四个领域,并按WHO区域和全球/区域/国家层级分层分析。结果选出六个最高优先级研究问题,且研究重点因区域和层级而异。

要点

  • 调查选出六个最高优先级研究问题,覆盖四个主题领域。
  • 研究重点因WHO区域和全球/区域/国家层级而异。
  • 结果可用于全球、区域和国家层面研究投资决策。

核心结论

  • 研究和创新对实现GVAP麻疹和风疹消除目标至关重要。
  • 调查结果可为全球、区域和国家层面研究活动投资决策提供参考。

研究设计与样本

  • 横断面网络调查,对象为科学和项目专家,由M&RI研究创新工作组开展。
  • 调查问题覆盖四个主题领域:流行病学与经济学、监测/疫苗递送/实验室检测新工具、免疫策略与疫情应对、疫苗需求与沟通。
  • 分析按六个WHO区域及全球、区域或国家/次国家层级分层。

主要发现

  • 受访者选出的六个最高优先级研究问题涉及:高报告接种率环境下的疫情原因、可负担的即时诊断检测、常规首剂麻疹疫苗覆盖率提升策略、第二剂覆盖率提升策略、社区参与健康服务规划实施监测、卫生工作者能力建设以有效合作社区领袖。
  • 所有主题领域的研究重点均因区域和全球/区域/国家层级而异。

临床怎么用

  • 调查结果可用于指导全球、区域和国家层面麻疹和风疹研究活动的投资决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan (GVAP) that set a target to eliminate measles and rubella in five of the six World Health Organization (WHO) regions by 2020. Significant progress has been made toward achieving this goal through intensive efforts by countries and Measles & Rubella Initiative (M&RI) partners. Accelerating progress will require evidence-based approaches to improve implementation of the core strategies in the Global Measles and Rubella Strategic Plan. The M&RI Research and Innovation Working Group (R&IWG) conducted a web-based survey as part of a process to identify measles and rubella research priorities. Survey findings were used to inform discussions during a meeting of experts convened by the M&RI at the Pan American Health Organization in November 2016. METHODS: The cross-sectional web-based survey of scientific and programmatic experts included questions in four main topic areas: (1) epidemiology and economics (epidemiology); (2) new tools for surveillance, vaccine delivery, and laboratory testing (new tools); (3) immunization strategies and outbreak response (strategies); and (4) vaccine demand and communications (demand). Analyses were stratified by the six WHO regions and by global, regional, or national/sub-national level of respondents. RESULTS: The six highest priority research questions selected by survey respondents from the four topic areas were the following: (1) What are the causes of outbreaks in settings with high reported vaccination coverage? (epidemiology); (2) Can affordable diagnostic tests be developed to confirm measles and rubella cases rapidly and accurately at the point of care? (new tools); (3) What are effective strategies for increasing coverage of the routine first dose of measles vaccine administered at 9 or 12 months? (strategies); (4) What are effective strategies for increasing coverage of the second dose given after the first year of life? (strategies); (5) How can communities best be engaged in planning, implementing and monitoring health services including vaccinations? (demand); (6) What capacity building is needed for health workers to be able to identify and work more effectively with community leaders? (demand). Research priorities varied by region and by global/regional/national levels for all topic areas. CONCLUSIONS: Research and innovation will be critical to make further progress toward achieving the GVAP measles and rubella elimination goals. The results of this survey can be used to inform decision-making for investments in research activities at the global, regional, and national levels.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kriss JL, Grant GB, Moss WJ, et al. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey. Vaccine. 2019. PMID: 30898393. doi:10.1016/j.vaccine.2019.02.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。